Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2

Table 3

Concentration of Ald and Ang II in plasma.

Group	N	Ang II (×10^−6 μg/mL)	ALD (×10^−3 μg/mL)
Sham-operated	8	165.59 ± 21.352*	208.85 ± 47.953
Model	8	211.28 ± 19.853^▲	220.32 ± 20.608
Fosinopril sodium	8	184.75 ± 29.096*	228.72 ± 17.603
QSYQ	8	176.71 ± 27.661*	236.49 ± 32.965

^▲P < 0.05 versus sham-operated group; *P < 0.05 versus model group.